Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery


 SYUA_RAT                Reviewed;         140 AA.
P37377; P37378; Q53YM9;
01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
01-OCT-1994, sequence version 1.
16-JAN-2019, entry version 156.
RecName: Full=Alpha-synuclein;
Rattus norvegicus (Rat).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Rattus.
PubMed=1661825; DOI=10.1016/0169-328X(91)90043-W;
Maroteaux L., Scheller R.H.;
"The rat brain synucleins; family of proteins transiently associated
with neuronal membrane.";
Brain Res. Mol. Brain Res. 11:335-343(1991).
Maroteaux L., Campanelli J.T., Scheller R.H.;
"Synuclein: a neuron-specific protein localized to the nucleus and
presynaptic nerve terminal.";
J. Neurosci. 8:2804-2815(1988).
PubMed=10582622; DOI=10.1046/j.1471-4159.1999.0732586.x;
Kholodilov N.G., Neystat M., Oo T.F., Lo S.E., Larsen K.E., Sulzer D.,
Burke R.E.;
"Increased expression of rat synuclein in the substantia nigra pars
compacta identified by mRNA differential display in a model of
developmental target injury.";
J. Neurochem. 73:2586-2599(1999).
STRAIN=Wistar; TISSUE=Brain;
PubMed=12665621; DOI=10.1073/pnas.0737182100;
Liang T., Spence J., Liu L., Strother W.N., Chang H.W., Ellison J.A.,
Lumeng L., Li T.K., Foroud T., Carr L.G.;
"Alpha-synuclein maps to a quantitative trait locus for alcohol
preference and is differentially expressed in alcohol-preferring and
- nonpreferring rats.";
Proc. Natl. Acad. Sci. U.S.A. 100:4690-4695(2003).
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
Lubec G., Chen W.-Q.;
Submitted (APR-2007) to UniProtKB.
PubMed=12408865; DOI=10.1016/S0092-8674(02)01012-7;
Liu Y., Fallon L., Lashuel H.A., Liu Z., Lansbury P.T. Jr.;
"The UCH-L1 gene encodes two opposing enzymatic activities that affect
alpha-synuclein degradation and Parkinson's disease susceptibility.";
Cell 111:209-218(2002).
PubMed=22673903; DOI=10.1038/ncomms1871;
Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
Lundby C., Olsen J.V.;
"Quantitative maps of protein phosphorylation sites across 14
different rat organs and tissues.";
Nat. Commun. 3:876-876(2012).
-!- FUNCTION: May be involved in the regulation of dopamine release
and transport.
-!- SUBUNIT: Interacts with UCHL1. {ECO:0000269|PubMed:12408865}.
-!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
{ECO:0000250|UniProtKB:P37840}. Membrane
{ECO:0000250|UniProtKB:P37840}. Nucleus
{ECO:0000250|UniProtKB:P37840}. Cell junction, synapse
{ECO:0000250|UniProtKB:P37840}. Secreted
Event=Alternative splicing; Named isoforms=3;
Comment=Additional isoforms seem to exist.;
IsoId=P37377-1; Sequence=Displayed;
IsoId=P37377-2; Sequence=VSP_006367;
IsoId=P37377-3; Sequence=VSP_006365, VSP_006366;
-!- TISSUE SPECIFICITY: Found only in brain (hippocampus, brainstem
and cortex). Specifically expressed in neuronal cell bodies and
-!- PTM: Phosphorylated, predominantly on serine residues.
Phosphorylated on Tyr-125 upon osmotic stress (By similarity).
-!- PTM: Ubiquitinated. The predominant conjugate is the
diubiquitinated form. {ECO:0000269|PubMed:12408865}.
-!- PTM: Acetylation at Met-1 seems to be important for proper folding
and native oligomeric structure. {ECO:0000250}.
-!- SIMILARITY: Belongs to the synuclein family. {ECO:0000305}.
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
EMBL; S73007; AAB20688.1; -; mRNA.
EMBL; S73008; AAB20689.1; -; mRNA.
EMBL; S73009; AAB20690.1; -; mRNA.
EMBL; AF007758; AAC16026.1; -; mRNA.
EMBL; AY550005; AAS55694.1; -; mRNA.
EMBL; AY550006; AAS55695.1; -; mRNA.
EMBL; BC087682; AAH87682.1; -; mRNA.
PIR; B43959; B43959.
RefSeq; NP_062042.1; NM_019169.2. [P37377-1]
RefSeq; XP_006236653.1; XM_006236591.3. [P37377-2]
RefSeq; XP_017447989.1; XM_017592500.1. [P37377-2]
UniGene; Rn.1827; -.
ProteinModelPortal; P37377; -.
SMR; P37377; -.
BioGrid; 247897; 79.
IntAct; P37377; 3.
iPTMnet; P37377; -.
PhosphoSitePlus; P37377; -.
World-2DPAGE; 0004:P37377; -.
jPOST; P37377; -.
PeptideAtlas; P37377; -.
PRIDE; P37377; -.
Ensembl; ENSRNOT00000039247; ENSRNOP00000030609; ENSRNOG00000008656. [P37377-1]
GeneID; 29219; -.
KEGG; rno:29219; -.
UCSC; RGD:3729; rat. [P37377-1]
CTD; 6622; -.
RGD; 3729; Snca.
GeneTree; ENSGT00940000154211; -.
HOGENOM; HOG000008691; -.
HOVERGEN; HBG000481; -.
InParanoid; P37377; -.
KO; K04528; -.
OrthoDB; 1544450at2759; -.
PhylomeDB; P37377; -.
TreeFam; TF332776; -.
PRO; PR:P37377; -.
Proteomes; UP000002494; Chromosome 4.
Bgee; ENSRNOG00000008656; Expressed in 10 organ(s), highest expression level in brain.
Genevisible; P37377; RN.
GO; GO:0015629; C:actin cytoskeleton; IEA:Ensembl.
GO; GO:0043679; C:axon terminus; IDA:RGD.
GO; GO:0005938; C:cell cortex; IEA:Ensembl.
GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
GO; GO:0005737; C:cytoplasm; IDA:RGD.
GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:BHF-UCL.
GO; GO:0005829; C:cytosol; IDA:RGD.
GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
GO; GO:0005794; C:Golgi apparatus; IDA:RGD.
GO; GO:0030426; C:growth cone; IDA:RGD.
GO; GO:0016234; C:inclusion body; IEA:Ensembl.
GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:RGD.
GO; GO:0005743; C:mitochondrial inner membrane; IDA:RGD.
GO; GO:0005758; C:mitochondrial intermembrane space; IDA:RGD.
GO; GO:0005759; C:mitochondrial matrix; IDA:RGD.
GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
GO; GO:0043025; C:neuronal cell body; IDA:RGD.
GO; GO:0005640; C:nuclear outer membrane; IDA:RGD.
GO; GO:0005634; C:nucleus; IDA:RGD.
GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
GO; GO:0005886; C:plasma membrane; IDA:RGD.
GO; GO:0031092; C:platelet alpha granule membrane; IEA:Ensembl.
GO; GO:0098794; C:postsynapse; IEA:GOC.
GO; GO:0098793; C:presynapse; IDA:RGD.
GO; GO:0005840; C:ribosome; IDA:RGD.
GO; GO:0005791; C:rough endoplasmic reticulum; IDA:RGD.
GO; GO:0099512; C:supramolecular fiber; IEA:Ensembl.
GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
GO; GO:0030672; C:synaptic vesicle membrane; IEA:Ensembl.
GO; GO:0043195; C:terminal bouton; IDA:RGD.
GO; GO:0003779; F:actin binding; IEA:Ensembl.
GO; GO:0043014; F:alpha-tubulin binding; IEA:Ensembl.
GO; GO:0050544; F:arachidonic acid binding; IEA:Ensembl.
GO; GO:0048487; F:beta-tubulin binding; IDA:RGD.
GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
GO; GO:1903136; F:cuprous ion binding; IEA:Ensembl.
GO; GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IEA:Ensembl.
GO; GO:0070840; F:dynein complex binding; IEA:Ensembl.
GO; GO:0019899; F:enzyme binding; IPI:RGD.
GO; GO:0008198; F:ferrous iron binding; IEA:Ensembl.
GO; GO:0042393; F:histone binding; IEA:Ensembl.
GO; GO:0030544; F:Hsp70 protein binding; IEA:Ensembl.
GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
GO; GO:0019894; F:kinesin binding; IEA:Ensembl.
GO; GO:0000287; F:magnesium ion binding; IEA:Ensembl.
GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
GO; GO:0016491; F:oxidoreductase activity; IEA:Ensembl.
GO; GO:0043274; F:phospholipase binding; IPI:RGD.
GO; GO:0005543; F:phospholipid binding; IDA:RGD.
GO; GO:0051219; F:phosphoprotein binding; IEA:Ensembl.
GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
GO; GO:0047485; F:protein N-terminus binding; IDA:RGD.
GO; GO:0048156; F:tau protein binding; IEA:Ensembl.
GO; GO:0008270; F:zinc ion binding; IEA:Ensembl.
GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
GO; GO:0007568; P:aging; IEP:RGD.
GO; GO:0048148; P:behavioral response to cocaine; IMP:RGD.
GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
GO; GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl.
GO; GO:0042416; P:dopamine biosynthetic process; IEA:Ensembl.
GO; GO:0060079; P:excitatory postsynaptic potential; IEA:Ensembl.
GO; GO:0006631; P:fatty acid metabolic process; IEA:Ensembl.
GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
GO; GO:0001774; P:microglial cell activation; IEA:Ensembl.
GO; GO:0042775; P:mitochondrial ATP synthesis coupled electron transport; IEA:Ensembl.
GO; GO:0007006; P:mitochondrial membrane organization; IEA:Ensembl.
GO; GO:1904715; P:negative regulation of chaperone-mediated autophagy; IEA:Ensembl.
GO; GO:0045963; P:negative regulation of dopamine metabolic process; IMP:BHF-UCL.
GO; GO:0051585; P:negative regulation of dopamine uptake involved in synaptic transmission; IEA:Ensembl.
GO; GO:0045920; P:negative regulation of exocytosis; IEA:Ensembl.
GO; GO:0035067; P:negative regulation of histone acetylation; IEA:Ensembl.
GO; GO:0031115; P:negative regulation of microtubule polymerization; IEA:Ensembl.
GO; GO:0032769; P:negative regulation of monooxygenase activity; IEA:Ensembl.
GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
GO; GO:1901215; P:negative regulation of neuron death; IMP:RGD.
GO; GO:0051622; P:negative regulation of norepinephrine uptake; IEA:Ensembl.
GO; GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; IEA:Ensembl.
GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:BHF-UCL.
GO; GO:0051612; P:negative regulation of serotonin uptake; IEA:Ensembl.
GO; GO:0070495; P:negative regulation of thrombin-activated receptor signaling pathway; IEA:Ensembl.
GO; GO:0032410; P:negative regulation of transporter activity; IEA:Ensembl.
GO; GO:0006638; P:neutral lipid metabolic process; IEA:Ensembl.
GO; GO:0006644; P:phospholipid metabolic process; IEA:Ensembl.
GO; GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl.
GO; GO:1903284; P:positive regulation of glutathione peroxidase activity; IEA:Ensembl.
GO; GO:1903285; P:positive regulation of hydrogen peroxide catabolic process; IEA:Ensembl.
GO; GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl.
GO; GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; IEA:Ensembl.
GO; GO:1901216; P:positive regulation of neuron death; IEA:Ensembl.
GO; GO:0001956; P:positive regulation of neurotransmitter secretion; IEA:Ensembl.
GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl.
GO; GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl.
GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl.
GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
GO; GO:0031623; P:receptor internalization; IEA:Ensembl.
GO; GO:0050812; P:regulation of acyl-CoA biosynthetic process; IEA:Ensembl.
GO; GO:0014059; P:regulation of dopamine secretion; IEA:Ensembl.
GO; GO:0014048; P:regulation of glutamate secretion; IEA:Ensembl.
GO; GO:0040012; P:regulation of locomotion; IEA:Ensembl.
GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl.
GO; GO:0043030; P:regulation of macrophage activation; IEA:Ensembl.
GO; GO:1901214; P:regulation of neuron death; IGI:ParkinsonsUK-UCL.
GO; GO:0010517; P:regulation of phospholipase activity; IEA:Ensembl.
GO; GO:1905606; P:regulation of presynapse assembly; IEA:Ensembl.
GO; GO:0022898; P:regulation of transmembrane transporter activity; IEA:Ensembl.
GO; GO:0042220; P:response to cocaine; IEP:RGD.
GO; GO:1904307; P:response to desipramine; IEP:RGD.
GO; GO:0034341; P:response to interferon-gamma; IEA:Ensembl.
GO; GO:0070555; P:response to interleukin-1; IEA:Ensembl.
GO; GO:0010040; P:response to iron(II) ion; IEA:Ensembl.
GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
GO; GO:0032026; P:response to magnesium ion; IEA:Ensembl.
GO; GO:0050808; P:synapse organization; IEA:Ensembl.
GO; GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl.
GO; GO:0048488; P:synaptic vesicle endocytosis; IEA:Ensembl.
GO; GO:0048489; P:synaptic vesicle transport; IEA:Ensembl.
InterPro; IPR001058; Synuclein.
InterPro; IPR002460; Synuclein_alpha.
PANTHER; PTHR13820; PTHR13820; 1.
PANTHER; PTHR13820:SF5; PTHR13820:SF5; 1.
Pfam; PF01387; Synuclein; 1.
1: Evidence at protein level;
Acetylation; Alternative splicing; Cell junction; Complete proteome;
Copper; Cytoplasm; Direct protein sequencing; Membrane; Metal-binding;
Nucleus; Phosphoprotein; Reference proteome; Repeat; Secreted;
Synapse; Ubl conjugation.
CHAIN 1 140 Alpha-synuclein.
REPEAT 20 30 1.
REPEAT 31 41 2.
REPEAT 42 56 3; approximate.
REPEAT 57 67 4.
REGION 20 67 4 X 11 AA tandem repeats of [EGS]-K-T-K-
METAL 2 2 Copper. {ECO:0000250}.
METAL 50 50 Copper. {ECO:0000250}.
MOD_RES 1 1 N-acetylmethionine.
MOD_RES 125 125 Phosphotyrosine; by FYN.
MOD_RES 129 129 Phosphoserine; by PLK2.
VAR_SEQ 42 42 S -> R (in isoform Syn3). {ECO:0000305}.
VAR_SEQ 43 140 Missing (in isoform Syn3). {ECO:0000305}.
PFLPT (in isoform Syn2).
SEQUENCE 140 AA; 14515 MW; 1FFD19CD3B9E636C CRC64;

Related products :

Catalog number Product name Quantity
hSNCA-ELISA Alpha-Synuclein (α-Synuclein, Alpha Synuclein, SNCA; Human) High Sensitivity ELISA Assay Kit
32-216 SNCG(also designated gamma-synuclein or breast cancer-specific protein 1),with 127-amino acid protein(about 14kDa), belongs to the synuclein family, which also includes alpha- and beta- synuclein.Thre 0.1 mg
32-215 Alpha-synuclein (SNCA), with 140-amino acid protein (about 15kDa), belongs to the synuclein family, which also includes beta- and gamma-synuclein. SNCA is a soluble protein, expressed principally in t 0.1 mL
PD17 BV-Synuclein. Recombinant baculovirus expressing alpha synuclein, Host: Spodoptera frugiperda, Trichoplusia ni 1 ml
PD17 BV-Synuclein. Recombinant baculovirus expressing alpha synuclein. 1 ml
SCH-AHP1537 RABBIT ANTI RAT ALPHA SYNUCLEIN (pSer129), Product Type Polyclonal Antibody, Specificity ALPHA SYNUCLEIN , Target Species Rat, Host Rabbit, Format Purified, Isotypes Polyclonal IgG, Applications 0.1 ml
AHP1537 RABBIT ANTI RAT ALPHA SYNUCLEIN (pSer129), Product Type Polyclonal Antibody, Specificity ALPHA SYNUCLEIN , Target Species Rat, Host Rabbit, Format Purified, Isotypes Polyclonal IgG, Applications 0.1 ml
20-002-35023 alpha-Synuclein (anti-alpha-Synuclein. 61-95 aa. clone 5C2) - Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP Monoclonal 0.1 ml
AHP493 GOAT ANTI HUMAN ALPHA SYNUCLEIN, Product Type Polyclonal Antibody, Specificity ALPHA SYNUCLEIN, Target Species Human, Host Goat, Format Serum, Isotypes Polyclonal IgG, Applications E, P, Clone 0.1 ml
SCH-AHP493 GOAT ANTI HUMAN ALPHA SYNUCLEIN, Product Type Polyclonal Antibody, Specificity ALPHA SYNUCLEIN, Target Species Human, Host Goat, Format Serum, Isotypes Polyclonal IgG, Applications E, P, Clone 0.1 ml
20-272-192257 alpha Synuclein - Mouse monoclonal [4B12] to alpha Synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP Monoclonal 0.1 ml
RSNCA-ELISA Rabbit Alpha-Synuclein (α-Synuclein, SNCA) High Sensitivity ELISA Assay Kit (2x96T)
orb72136 Synuclein alpha peptide This is Synuclein alpha peptide. For research use only. 1 mg
20-272-192256 alpha Synuclein - Mouse monoclonal [4D6] to alpha Synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP Monoclonal 0.1 ml
18-272-196445 alpha Synuclein - Rabbit polyclonal to alpha Synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP Polyclonal 0.5 ml
orb80933 Human Alphalpha Synuclein protein alpha Synuclein Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain of 140 amino acids having a molecular mass of 14.4kDa. The Recomb 20
18-272-196446 alpha Synuclein prediluted - Rabbit polyclonal to alpha Synuclein prediluted; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP Polyclonal 7 ml
48-658 Alpha-Synuclein Antibody 0.05 mg
50-241 Alpha synuclein Antibody 0.1 mL
Q06241M MAb to Synuclein Alpha 100ul
Q06604M MAb to Synuclein Alpha 100ul
pro-393 Recombinant Human Alpha-Synuclein 1mg
GWB-DA182E Alpha-Synuclein, Antibody
BMRB-9026-B1 Synuclein alpha 0.5mL
pro-163 Recombinant Human Alpha-Synuclein 61-140 1mg

https://antibody-antibodies.com/ | https://gentaur.com/ | https://gen-script.com/ | https://diagenox.com/ | https://clonagen.com/ | http://gentaursearch.com/ | http://gentaurpub.com/ | https://gentaur-online.com/ | http://anti-anti-pdf.com/ | http://gentaur-worldwide.com/


GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur

Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur



9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123

GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

spain@gentaur.com | Gentaur | Gentaur

ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636

GENTAUR Poland Sp. z o.o.

ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556


Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur